Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes

Status unconfirmed

Conditions studied: Adult, Myelodysplastic Syndromes

In brief

RATIONALE: Gathering information about quality of life, fatigue, and other symptoms from patients with myelodysplastic syndromes may help doctors learn more about the disease and may help plan treatment. PURPOSE: This clinical trial is studying quality of life and symptoms in patients with newly diagnosed myelodysplastic syndromes.

Key facts

Study ID

NCT00809575

Run by

Gruppo Italiano Malattie EMatologiche dell'Adulto

People needed

927

Starts

2008-10-02

Expected to finish

2021-02-01

Last updated by the study team

2020-12-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with newly diagnosed myelodysplastic syndrome (MDS) according to WHO classification with any known IPSS risk score category. The initial diagnosis of MDS is acceptable within 3 months before date of registration.
• Having a full baseline QoL Evaluation completed (i.e. EORTC QLQ-C30; EQ5D; FACIT-Fatigue and Control Preference Scale).
• Adult patients (≥ 18 years old).
• Written informed consent provided.

You may not qualify if…

• Patients who have received prior treatment other than platelets or RBC transfusions, iron chelation, antibiotic/virostatic drugs, vitamins;
• Patients with therapy related MDS.
• Having any kind of psychiatric disorder or major cognitive dysfunction.
• Not able to read and understand local language.

Where it is running

• The University of Texas, MD Anderson Cancer Center — Houston, Texas, United States
• Innsbruck University Hospital — Innsbruck, Austria
• ZNA Middelheim — Antwerp, Belgium
• AZ Sint-Jan AV, Department of Hematology — Bruges, Belgium
• CH Jolimont — Brussels, Belgium
• CHC - Centre Hospitalier Chrétien — Liège, Belgium
• Curitiba Unidade de Hematologia - Hemoterapia e Oncologia. Setor de Transplante de Medula Ossea. Complexo Hospital de Clinicas da Universidade Federal do Parana (CHC-UFPR) — Curitiba, Brazil
• Affiliated Hospital of Liaoning University of Traditional Chinese Medicine — China, China
• Kunming Medical University — Kunming, China
• Hematology - Clinical Hospital Centre Rijeka - Faculty of Medicine - University of Rijeka — Rijeka, Croatia
• General Teaching Hospital — Prague, Czechia
• Saint - Cloud Medecin des CLCC Hematologie Service E Hopital ReneHuguenin - Institut Curie — Saint-Cloud, France
• Purpan Hospital - Internal Medicine Department — Toulouse, France
• Department of Hematology - Universitatsklinikum Carl Gustav Carus — Dresden, Germany
• University of Freiburg Medical Center — Freiburg im Breisgau, Germany
• Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza — San Giovanni Rotondo, Foggia, Italy
• U.O.A. di Medicina Trasfusionale e DH di Ematologia - ASL TO 4 Ospedale di Ivrea — Ivrea, Torino, Italy
• Asl Di Asti - Ospedali Riuniti - Presidio Ospedaliero Cardinal G. Massaia - Sc Oncologia — Asti, Italy
• Unità Operativa Ematologia 1 - Università degli Studi di Bari — Bari, Italy
• ASL N.8 - Ospedale "A. Businco" - Unità Operativa di Ematologia e Trapianto di Midollo — Cagliari, Italy
• CTMO - Ematologia - Ospedale "Binaghi" — Cagliari, Italy
• Ospedale "Ferrarotto" — Catania, Italy
• A.O. Pugliese Ciaccio — Catanzaro, Italy
• Aou Arcispedale Sant'Anna - Uoc Ematologia E Fisiopatologia Della Coagulazione — Cona, Italy
• Memorial Sloan-Kettering Cancer Center (MSKCC) — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.